US2010234939A1PendingUtilityA1

Biological valve for venous valve insufficiency

49
Assignee: HANCOCK JAFFE LABPriority: Oct 17, 2007Filed: May 27, 2010Published: Sep 16, 2010
Est. expiryOct 17, 2027(~1.3 yrs left)· nominal 20-yr term from priority
Inventors:Norman Jaffe
A61F 2/2412A61L 27/3625A61F 2/2475A61F 2/2415A61L 27/507
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A bioprosthetic valve for repairing a deep venous insufficiency in a subject includes a single leaflet from a xenogeneic heart valve attached at natural margins of attachment to a patch of valve wall tissue. The patch may extend axially above and below the leaflet and circumferentially on either side of the leaflet to provide a region for attaching the patch to a fenestration in a host vein. A bioprosthetic valve may be manufactured by excising a portion of a xenogeneic heart valve including a single leaflet and contiguous wall tissue, and may further comprise shaving off excess leaflet tissue from adjacent leaflets. A method of replacing a malfunctioning venous valve in a subject includes providing a bioprosthetic valve as described above and inserting it to the host vein.

Claims

exact text as granted — not AI-modified
1 . A method of treating a malfunctioning valve in a host vein of a subject, the method comprising:
 providing a replacement biological valve comprising a single leaflet from a xenogeneic heart valve attached at natural margins of attachment to a patch of contiguous tissue from the xenogeneic heart valve; and   inserting said replacement biological valve into said host vein.   
     
     
         2 . The method of  claim 1 , further comprising creating a fenestration in the host vein in the region of the malfunctioning valve, the fenestration having a shape generally corresponding to the patch. 
     
     
         3 . The method of  claim 2 , wherein the fenestration is created generally in the region of the malfunctioning valve. 
     
     
         4 . The method of  claim 2 , wherein the fenestration is created generally above the region of the malfunctioning valve. 
     
     
         5 . The method of  claim 2 , wherein the fenestration is created generally below the region of the malfunctioning valve. 
     
     
         6 . The method of  claim 2 , further comprising attaching the replacement biological valve to the host vein at the fenestration. 
     
     
         7 . The method of  claim 1 , further comprising removing at least one leaflet from the malfunctioning valve of the host vein. 
     
     
         8 . The method of  claim 1 , wherein the xenogeneic heart valve is a porcine aortic valve. 
     
     
         9 . The method of  claim 8 , wherein the single leaflet is a noncoronary leaflet. 
     
     
         10 . The method of  claim 1 , wherein the leaflet and patch have been subjected to a fixation treatment. 
     
     
         11 . The method of  claim 10 , wherein the fixation treatment includes exposing the leaflet and patch to glutaraldehyde solution. 
     
     
         12 . The method of  claim 1 , wherein the subject is human. 
     
     
         13 . A method of manufacturing a replacement venous valve for a host vein in a subject, the method comprising:
 obtaining a xenogeneic heart valve, the heart valve having at least one leaflet and a valve wall, the heart valve having been subjected to a fixation treatment;   excising a portion of the heart valve, the portion comprising at least a selected leaflet attached at natural margins of attachment to a patch of valve wall tissue, such that said excised portion comprises a single leaflet; and   configuring the patch such that the patch is suitable for attachment to said host vein.   
     
     
         14 . The method of  claim 13 , wherein the xenogeneic heart valve is porcine. 
     
     
         15 . The method of  claim 13 , wherein the patch extends circumferentially on either side of the selected leaflet to provide a region for attachment to the host vein. 
     
     
         16 . The method of  claim 13 , wherein the patch extends axially above and below the selected leaflet to provide a region for attachment to the host vein. 
     
     
         17 . The method of  claim 13 , wherein the xenogeneic heart valve is an aortic valve. 
     
     
         18 . The method of  claim 17 , wherein the selected leaflet is a noncoronary leaflet. 
     
     
         19 . The method of  claim 13 , further comprising cutting through each natural commissure of the selected leaflet and shaving off tissue of any leaflets adjacent to the selected leaflet. 
     
     
         20 . The method of  claim 13 , wherein the subject is human.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.